Continued improvements in the treatment of pulmonary infections have paradoxically
resulted in a growing challenge of individuals with postinfectious pulmonary complications …

Background: Post-acute sequelae of SARS-CoV-2 infection (PASC) is a complicated
disease that affects millions of people all over the world. Previous studies have shown that …

Coronavirus disease 2019 (COVID-19) may determine a multisystemic chronic syndrome
after resolution of SARS-CoV-2 infection in a significant percentage of patients. Persistent …

SARS-CoV-2 infection causes transient cardiorespiratory and neurological disorders, and
severe acute illness is rare among children. Post COVID-19 condition (PCC) may cause …

The COVID-19 disease is an ongoing global health concern. Although vaccination provides
some protection, people are still susceptible to re-infection. Ostensibly, certain populations …

Post-COVID symptoms are reported in 10–35% of patients not requiring hospitalization, and
in up to 80% of hospitalized patients and patients with severe disease. The pathogenesis of …

Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease
worldwide. Macrophage polarization plays a substantial role in the pathogenesis of COPD …

Long COVID (LC) is a condition where the patient experiences sequelae for at least two
months after a period of three months following the initial SARS-CoV-2 infection, and these …

COVID-19 pandemic represented a worldwide challenge in the past 3 years. Even if the
emergency is ending, the identification of the main prognostic factors that determine the …

COVID-19 is the syndrome caused by SARS-CoV-2 infection. Severe phenotypes seem to
be caused by a “cytokines storm” and pneumonia is one of the most important clinical …